194 related articles for article (PubMed ID: 19722898)
1. DNA vaccine manufacture: scale and quality.
Cai Y; Rodriguez S; Hebel H
Expert Rev Vaccines; 2009 Sep; 8(9):1277-91. PubMed ID: 19722898
[TBL] [Abstract][Full Text] [Related]
2. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
Cai Y; Rodriguez S; Rameswaran R; Draghia-Akli R; Juba RJ; Hebel H
Vaccine; 2010 Feb; 28(8):2046-52. PubMed ID: 19896448
[TBL] [Abstract][Full Text] [Related]
3. Plasmid DNA for pharmaceutical applications.
Schleef M; Schmidt T; Flaschel E
Dev Biol (Basel); 2000; 104():25-31. PubMed ID: 11713820
[TBL] [Abstract][Full Text] [Related]
4. Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications.
Sousa A; Tomaz CT; Sousa F; Queiroz JA
J Chromatogr A; 2011 Nov; 1218(46):8333-43. PubMed ID: 21995857
[TBL] [Abstract][Full Text] [Related]
5. [Pilot-scale production and quality control of multiepitope hepatitis B virus DNA vaccine].
Guo Y; Hui CY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):118-20. PubMed ID: 19218129
[TBL] [Abstract][Full Text] [Related]
6. Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA.
Shamlou PA
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):207-18. PubMed ID: 12683955
[TBL] [Abstract][Full Text] [Related]
7. Plasmid fermentation process for DNA immunization applications.
Carnes AE; Williams JA
Methods Mol Biol; 2014; 1143():197-217. PubMed ID: 24715290
[TBL] [Abstract][Full Text] [Related]
8. Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules.
Zhang S; Krivosheyeva A; Nochumson S
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):245-9. PubMed ID: 12656677
[TBL] [Abstract][Full Text] [Related]
9. GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.
Quaak SG; van den Berg JH; Toebes M; Schumacher TN; Haanen JB; Beijnen JH; Nuijen B
Eur J Pharm Biopharm; 2008 Oct; 70(2):429-38. PubMed ID: 18606527
[TBL] [Abstract][Full Text] [Related]
10. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications.
Ferreira GN; Cabral JM; Prazeres DM
Biotechnol Prog; 1999; 15(4):725-31. PubMed ID: 10441364
[TBL] [Abstract][Full Text] [Related]
11. Animal-free production of ccc-supercoiled plasmids for research and clinical applications.
Schleef M; Schmidt T
J Gene Med; 2004 Feb; 6 Suppl 1():S45-53. PubMed ID: 14978750
[TBL] [Abstract][Full Text] [Related]
12. A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseases.
Kaslow DC
Trans R Soc Trop Med Hyg; 2004 Oct; 98(10):593-601. PubMed ID: 15289096
[TBL] [Abstract][Full Text] [Related]
13. Optimizing alkaline lysis for DNA plasmid recovery.
Clemson M; Kelly WJ
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):235-44. PubMed ID: 12611593
[TBL] [Abstract][Full Text] [Related]
14. Production and purification of plasmid DNA vaccines: is there scope for further innovation?
Xenopoulos A; Pattnaik P
Expert Rev Vaccines; 2014 Dec; 13(12):1537-51. PubMed ID: 25308708
[TBL] [Abstract][Full Text] [Related]
15. A simple method for the production of plasmid DNA in bioreactors.
Listner K; Bentley LK; Chartrain M
Methods Mol Med; 2006; 127():295-309. PubMed ID: 16988462
[TBL] [Abstract][Full Text] [Related]
16. Assuring the quality, safety, and efficacy of DNA vaccines.
Robertson JS; Griffiths E
Mol Biotechnol; 2001 Feb; 17(2):143-9. PubMed ID: 11395863
[TBL] [Abstract][Full Text] [Related]
17. Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies.
Przybylowski M; Bartido S; Borquez-Ojeda O; Sadelain M; Rivière I
Vaccine; 2007 Jun; 25(27):5013-24. PubMed ID: 17537555
[TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA of high quality purified by activated charcoal.
Kim JY; Cho C; Cho BN
J Biosci Bioeng; 2010 Nov; 110(5):608-13. PubMed ID: 20638332
[TBL] [Abstract][Full Text] [Related]
19. Improved downstream process for the production of plasmid DNA for gene therapy.
Urthaler J; Buchinger W; Necina R
Acta Biochim Pol; 2005; 52(3):703-11. PubMed ID: 16175245
[TBL] [Abstract][Full Text] [Related]
20. Engineering of bacterial strains and vectors for the production of plasmid DNA.
Bower DM; Prather KL
Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
